McKessonHBOC Gives Ex-CEO Pulido $17.5 Mil. Severance Package
Executive Summary
McKessonHBOC is providing former CEO Mark Pulido with a severance package worth $17.5 mil.
You may also be interested in...
Bergen Pursues Legislative, Managerial Remedies for PharMerica
Reimbursement pressure on Bergen Brunswig's PharMerica long-term care pharmacy business is prompting the parent company to lobby for changes to Medicare's Prospective Payment System.
McKesson Splits CEO Into Operations & Strategy: Hammergren & Mahoney
McKessonHBOC is relying on two young McKesson execs acting as a two-person CEO office to drive the integration of distribution and information businesses into a company able to link each episode of care from first patient contact to prescription dispensing.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011